| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.772 | 0.015 | 0.772 | Caspase 9 stimulant | 0.496 0.061 CID_2201 | ||
| 0.76 | 0.005 | 0.76 | Aldehyde oxidase inhibitor | 0.724 0.007 CID_2201 | ||
| 0.622 | 0.005 | 0.622 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.559 0.014 CID_2201 | ||
| 0.55 | 0.014 | 0.575 | GABA C receptor rho-3 antagonist | 0.575 0.01 CID_2201 | CID_2201 | |
| 0.524 | 0.021 | 0.524 | Aryl hydrocarbon receptor agonist | 0.243 0.082 CID_2201 | ||
| 0.483 | 0.005 | 0.483 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.434 | 0.005 | 0.434 | Aldehyde dehydrogenase inhibitor | 0.341 0.008 CID_2201 | ||
| 0.427 | 0.004 | 0.52 | Porphobilinogen synthase inhibitor | 0.52 0.003 CID_2201 | CID_2201 | |
| 0.38 | 0.003 | 0.38 | CYP2A6 inhibitor | 0.125 0.025 CID_2201 | ||
| 0.371 | 0.01 | 0.717 | Alpha-N-acetylglucosaminidase inhibitor | 0.717 0.003 CID_2201 | CID_2201 | |
| 0.417 | 0.068 | 0.681 | 5 Hydroxytryptamine release inhibitor | 0.681 0.005 CID_2201 | CID_2201 | |
| 0.434 | 0.098 | 0.434 | Apoptosis agonist | 0.405 0.111 CID_2201 | ||
| 0.333 | 0.006 | 0.333 | 3C-like protease (Human coronavirus) inhibitor | 0.255 0.025 CID_2201 | ||
| 0.346 | 0.024 | 0.346 | Anesthetic general | 0.265 0.044 CID_2201 | ||
| 0.324 | 0.013 | 0.324 | Neurotrophic factor enhancer | 0.263 0.032 CID_2201 | ||
| 0.349 | 0.059 | 0.561 | Caspase 3 stimulant | 0.561 0.013 CID_2201 | CID_2201 | |
| 0.318 | 0.034 | 0.475 | Peroxidase inhibitor | 0.475 0.012 CID_2201 | CID_2201 | |
| 0.268 | 0.01 | 0.268 | 5 Hydroxytryptamine 3E antagonist | 0.215 0.041 CID_2201 | ||
| 0.355 | 0.098 | 0.625 | Histamine release inhibitor | 0.625 0.008 CID_2201 | CID_2201 | |
| 0.294 | 0.036 | 0.347 | Tyrosine 3 hydroxylase inhibitor | 0.347 0.017 CID_2201 | CID_2201 | |
| 0.299 | 0.045 | 0.434 | 5 Hydroxytryptamine uptake stimulant | 0.434 0.009 CID_2201 | CID_2201 | |
| 0.288 | 0.048 | 0.363 | DNA synthesis inhibitor | 0.363 0.028 CID_2201 | CID_2201 | |
| 0.321 | 0.085 | 0.321 | Transcription factor NF kappa B inhibitor | 0.294 0.097 CID_2201 | ||
| 0.242 | 0.01 | 0.242 | Toll-Like receptor 2 antagonist | 0.186 0.031 CID_2201 | ||
| 0.25 | 0.022 | 0.412 | Succinate dehydrogenase inhibitor | 0.412 0.004 CID_2201 | CID_2201 | |
| 0.237 | 0.01 | 0.294 | Histidine decarboxylase inhibitor | 0.294 0.007 CID_2201 | CID_2201 | |
| 0.224 | 0.004 | 0.224 | Purinergic P2X2 antagonist | |||
| 0.282 | 0.065 | 0.282 | DNA damaging | 0.207 0.11 CID_2201 | ||
| 0.244 | 0.029 | 0.244 | Melanin inhibitor | 0.19 0.046 CID_2201 | ||
| 0.317 | 0.104 | 0.317 | Calpain 2 inhibitor | |||
| 0.227 | 0.016 | 0.615 | GABA C receptor agonist | 0.615 0.003 CID_2201 | CID_2201 | |
| 0.226 | 0.019 | 0.235 | Mannose-6-phosphate isomerase inhibitor | 0.235 0.016 CID_2201 | CID_2201 | |
| 0.225 | 0.018 | 0.282 | GABA C receptor rho-2 antagonist | 0.282 0.007 CID_2201 | CID_2201 | |
| 0.248 | 0.044 | 0.365 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.365 0.01 CID_2201 | CID_2201 | |
| 0.28 | 0.076 | 0.31 | 5 Hydroxytryptamine release stimulant | 0.31 0.067 CID_2201 | CID_2201 | |
| 0.265 | 0.061 | 0.265 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.154 0.127 CID_2201 | ||
| 0.266 | 0.065 | 0.484 | Superoxide dismutase inhibitor | 0.484 0.014 CID_2201 | CID_2201 | |
| 0.229 | 0.03 | 0.231 | Phospholipase C inhibitor | 0.231 0.03 CID_2201 | CID_2201 | |
| 0.295 | 0.097 | 0.381 | Calcium channel activator | 0.381 0.032 CID_2201 | CID_2201 | |
| 0.217 | 0.019 | 0.454 | Ferrochelatase inhibitor | 0.454 0.003 CID_2201 | CID_2201 | |
| 0.253 | 0.062 | 0.253 | Calpain inhibitor | 0.172 0.146 CID_2201 | ||
| 0.202 | 0.012 | 0.346 | Alcohol dehydrogenase inhibitor | 0.346 0.004 CID_2201 | CID_2201 | |
| 0.192 | 0.003 | 0.192 | Granulocyte macrophage colony stimulating factor agonist | 0.142 0.007 CID_2201 | ||
| 0.199 | 0.011 | 0.219 | Phosphofructokinase-1 inhibitor | 0.219 0.009 CID_2201 | CID_2201 | |
| 0.236 | 0.051 | 0.246 | CDC-like kinase 4 inhibitor | 0.246 0.047 CID_2201 | CID_2201 | |
| 0.282 | 0.098 | 0.282 | Apoptosis antagonist | 0.236 0.141 CID_2201 | ||
| 0.195 | 0.012 | 0.195 | TRPA1 agonist | 0.156 0.027 CID_2201 | ||
| 0.231 | 0.048 | 0.231 | LIM domain kinase 1 inhibitor | 0.141 0.107 CID_2201 | ||
| 0.276 | 0.094 | 0.276 | 12-Lipoxygenase inhibitor | 0.251 0.108 CID_2201 | ||
| 0.19 | 0.01 | 0.19 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.171 0.014 CID_2201 | ||
| 0.183 | 0.005 | 0.183 | Sphingosine 1-phosphate receptor 4 agonist | 0.141 0.01 CID_2201 | ||
| 0.196 | 0.02 | 0.243 | Xanthine oxidase inhibitor | 0.243 0.013 CID_2201 | CID_2201 | |
| 0.203 | 0.03 | 0.203 | Toll-Like receptor antagonist | |||
| 0.185 | 0.014 | 0.185 | Papain-like protease (SARS coronavirus) inhibitor | 0.168 0.021 CID_2201 | ||
| 0.207 | 0.038 | 0.246 | Interferon gamma antagonist | 0.246 0.029 CID_2201 | CID_2201 | |
| 0.182 | 0.014 | 0.182 | Sphingosine 1-phosphate receptor 4 antagonist | 0.167 0.021 CID_2201 | ||
| 0.184 | 0.02 | 0.364 | UDP-glucose 4-epimerase inhibitor | 0.364 0.007 CID_2201 | CID_2201 | |
| 0.166 | 0.004 | 0.166 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.121 0.007 CID_2201 | ||
| 0.174 | 0.012 | 0.243 | Glutamate dehydrogenase inhibitor | 0.243 0.007 CID_2201 | CID_2201 | |
| 0.228 | 0.068 | 0.228 | Pyruvate kinase inhibitor | 0.189 0.088 CID_2201 | ||
| 0.237 | 0.078 | 0.28 | Dyrk kinase inhibitor | 0.28 0.059 CID_2201 | CID_2201 | |
| 0.175 | 0.018 | 0.292 | HIV-1 integrase (Overall Integration) inhibitor | 0.292 0.004 CID_2201 | CID_2201 | |
| 0.176 | 0.02 | 0.235 | Protein kinase C gamma inhibitor | 0.235 0.008 CID_2201 | CID_2201 | |
| 0.189 | 0.033 | 0.189 | Neurotrophic factor | |||
| 0.224 | 0.07 | 0.295 | RNA-directed DNA polymerase inhibitor | 0.295 0.033 CID_2201 | CID_2201 | |
| 0.178 | 0.024 | 0.178 | GABA receptor agonist | 0.112 0.064 CID_2201 | ||
| 0.162 | 0.013 | 0.162 | Estrogen receptor beta antagonist | 0.103 0.059 CID_2201 | ||
| 0.193 | 0.044 | 0.193 | Protein kinase stimulant | 0.178 0.051 CID_2201 | ||
| 0.157 | 0.009 | 0.157 | Alpha tubulin antagonist | |||
| 0.163 | 0.017 | 0.384 | Triose-phosphate isomerase inhibitor | 0.384 0.004 CID_2201 | CID_2201 | |
| 0.152 | 0.007 | 0.153 | Purinergic P2X1 antagonist | 0.153 0.007 CID_2201 | CID_2201 | |
| 0.211 | 0.068 | 0.356 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.356 0.016 CID_2201 | CID_2201 | |
| 0.174 | 0.031 | 0.349 | Cystathionine beta-synthase inhibitor | 0.349 0.006 CID_2201 | CID_2201 | |
| 0.178 | 0.038 | 0.184 | Monophenol monooxygenase inhibitor | 0.184 0.037 CID_2201 | CID_2201 | |
| 0.161 | 0.023 | 0.197 | Ca2+-transporting ATPase inhibitor | 0.197 0.004 CID_2201 | CID_2201 | |
| 0.156 | 0.019 | 0.286 | GABA C receptor rho-1 antagonist | 0.286 0.004 CID_2201 | CID_2201 | |
| 0.205 | 0.068 | 0.249 | Insulin sensitizer | 0.249 0.035 CID_2201 | CID_2201 | |
| 0.155 | 0.019 | 0.155 | Protein kinase C zeta inhibitor | 0.103 0.047 CID_2201 | ||
| 0.256 | 0.121 | 0.571 | Cholesterol antagonist | 0.571 0.022 CID_2201 | CID_2201 | |
| 0.155 | 0.022 | 0.155 | Beta glucuronidase inhibitor | 0.131 0.036 CID_2201 | ||
| 0.142 | 0.009 | 0.163 | GABA aminotransferase inhibitor | 0.163 0.006 CID_2201 | CID_2201 | |
| 0.137 | 0.006 | 0.211 | CD45 antagonist | 0.211 0.004 CID_2201 | CID_2201 | |
| 0.157 | 0.027 | 0.222 | Photosensitizer | 0.222 0.009 CID_2201 | CID_2201 | |
| 0.147 | 0.018 | 0.147 | Thioredoxin inhibitor | |||
| 0.237 | 0.109 | 0.334 | Insulysin inhibitor | 0.334 0.04 CID_2201 | CID_2201 | |
| 0.154 | 0.026 | 0.154 | Pim-1 kinase inhibitor | |||
| 0.155 | 0.027 | 0.285 | GABA C receptor antagonist | 0.285 0.005 CID_2201 | CID_2201 | |
| 0.138 | 0.011 | 0.716 | Alcohol oxidase inhibitor | 0.716 0.003 CID_2201 | CID_2201 | |
| 0.156 | 0.029 | 0.174 | Mucolytic | 0.174 0.021 CID_2201 | CID_2201 | |
| 0.149 | 0.024 | 0.149 | Estrogen antagonist | 0.11 0.075 CID_2201 | ||
| 0.149 | 0.024 | 0.149 | Transcription factor STAT6 inhibitor | 0.124 0.054 CID_2201 | ||
| 0.162 | 0.038 | 0.184 | Adenylate cyclase inhibitor | 0.184 0.029 CID_2201 | CID_2201 | |
| 0.15 | 0.026 | 0.3 | Adenylate kinase inhibitor | 0.3 0.007 CID_2201 | CID_2201 | |
| 0.14 | 0.018 | 0.14 | GABA A receptor agonist | 0.079 0.066 CID_2201 | ||
| 0.178 | 0.056 | 0.211 | Arachidonic acid antagonist | 0.211 0.023 CID_2201 | CID_2201 | |
| 0.196 | 0.076 | 0.206 | Histone acetyltransferase inhibitor | 0.206 0.06 CID_2201 | CID_2201 | |
| 0.134 | 0.015 | 0.134 | Aromatase inhibitor | |||
| 0.141 | 0.023 | 0.141 | Anabolic | 0.137 0.026 CID_2201 | ||
| 0.199 | 0.081 | 0.199 | Psychostimulant | 0.17 0.1 CID_2201 | ||
| 0.132 | 0.015 | 0.132 | Estrogen receptor alpha antagonist | 0.088 0.037 CID_2201 | ||
| 0.194 | 0.079 | 0.355 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.355 0.026 CID_2201 | CID_2201 | |
| 0.124 | 0.011 | 0.124 | Elastase 1 inhibitor | 0.069 0.047 CID_2201 | ||
| 0.14 | 0.027 | 0.215 | DOPA decarboxylase inhibitor | 0.215 0.005 CID_2201 | CID_2201 | |
| 0.2 | 0.088 | 0.212 | Nitric-oxide synthase stimulant | 0.212 0.07 CID_2201 | CID_2201 | |
| 0.142 | 0.03 | 0.142 | Antineoplastic alkaloid | 0.084 0.06 CID_2201 | ||
| 0.117 | 0.009 | 0.134 | AMPA receptor antagonist | 0.134 0.007 CID_2201 | CID_2201 | |
| 0.129 | 0.021 | 0.129 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.119 0.025 CID_2201 | ||
| 0.138 | 0.03 | 0.284 | Creatine kinase inhibitor | 0.284 0.004 CID_2201 | CID_2201 | |
| 0.135 | 0.028 | 0.135 | CDC-like kinase 3 inhibitor | |||
| 0.107 | 0.005 | 0.107 | Catechol O-methyltransferase inhibitor | |||
| 0.134 | 0.032 | 0.385 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.385 0.004 CID_2201 | CID_2201 | |
| 0.225 | 0.123 | 0.274 | Hypoxia-inducible factor 1 alpha inhibitor | 0.274 0.08 CID_2201 | CID_2201 | |
| 0.109 | 0.009 | 0.109 | Estradiol 17 beta-dehydrogenase inhibitor | 0.054 0.023 CID_2201 | ||
| 0.128 | 0.029 | 0.128 | Androgen antagonist | 0.075 0.071 CID_2201 | ||
| 0.126 | 0.028 | 0.126 | Pim-3 kinase inhibitor | |||
| 0.103 | 0.005 | 0.103 | Glucose-6-phosphate translocase inhibitor | |||
| 0.139 | 0.042 | 0.139 | Interleukin 8 antagonist | 0.12 0.062 CID_2201 | ||
| 0.176 | 0.079 | 0.24 | CDC-like kinase 2 inhibitor | 0.24 0.049 CID_2201 | CID_2201 | |
| 0.121 | 0.025 | 0.159 | Ornithine decarboxylase inhibitor | 0.159 0.009 CID_2201 | CID_2201 | |
| 0.098 | 0.004 | 0.098 | Pregnane X receptor antagonist | 0.081 0.006 CID_2201 | ||
| 0.112 | 0.019 | 0.112 | Beta tubulin antagonist | |||
| 0.259 | 0.168 | 0.426 | Antibacterial | 0.426 0.065 CID_2201 | CID_2201 | |
| 0.158 | 0.067 | 0.158 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.112 | 0.022 | 0.118 | HIV-1 integrase (3'-Processing) inhibitor | 0.118 0.02 CID_2201 | CID_2201 | |
| 0.105 | 0.016 | 0.105 | TRPA1 antagonist | |||
| 0.118 | 0.03 | 0.275 | NADH dehydrogenase inhibitor | 0.275 0.007 CID_2201 | CID_2201 | |
| 0.134 | 0.045 | 0.134 | 5 Hydroxytryptamine 3A agonist | 0.095 0.082 CID_2201 | ||
| 0.155 | 0.067 | 0.169 | CF transmembrane conductance regulator agonist | 0.169 0.048 CID_2201 | CID_2201 | |
| 0.142 | 0.054 | 0.142 | Antibacterial (Helicobacter pylori) | 0.109 0.099 CID_2201 | ||
| 0.108 | 0.021 | 0.108 | Benzodiazepine agonist | |||
| 0.115 | 0.028 | 0.147 | Macrophage migration inhibitory factor inhibitor | 0.147 0.016 CID_2201 | CID_2201 | |
| 0.131 | 0.044 | 0.156 | Expectorant | 0.156 0.033 CID_2201 | CID_2201 | |
| 0.15 | 0.063 | 0.17 | Adenylate cyclase stimulant | 0.17 0.035 CID_2201 | CID_2201 | |
| 0.108 | 0.021 | 0.171 | D-Ala-D-Ala ligase inhibitor | 0.171 0.004 CID_2201 | CID_2201 | |
| 0.25 | 0.164 | 0.313 | 15-Lipoxygenase inhibitor | 0.313 0.123 CID_2201 | CID_2201 | |
| 0.118 | 0.032 | 0.128 | Lanosterol 14 alpha demethylase inhibitor | 0.128 0.023 CID_2201 | CID_2201 | |
| 0.153 | 0.068 | 0.153 | CDC-like kinase 1 inhibitor | |||
| 0.201 | 0.119 | 0.208 | Immunostimulant | 0.208 0.115 CID_2201 | CID_2201 | |
| 0.089 | 0.007 | 0.089 | Squalene epoxidase inhibitor | 0.061 0.02 CID_2201 | ||
| 0.158 | 0.078 | 0.158 | Heat shock protein 90 alpha antagonist | 0.135 0.104 CID_2201 | ||
| 0.152 | 0.072 | 0.282 | Phospholipase A2 inhibitor | 0.282 0.016 CID_2201 | CID_2201 | |
| 0.096 | 0.017 | 0.096 | Protease 3C (Human rhinovirus) inhibitor | 0.064 0.045 CID_2201 | ||
| 0.087 | 0.011 | 0.31 | Aconitate hydratase inhibitor | 0.31 0.002 CID_2201 | CID_2201 | |
| 0.142 | 0.067 | 0.189 | Heat shock protein 70 antagonist | 0.189 0.009 CID_2201 | CID_2201 | |
| 0.086 | 0.012 | 0.123 | Topoisomerase II beta inhibitor | 0.123 0.007 CID_2201 | CID_2201 | |
| 0.134 | 0.059 | 0.173 | Cathepsin H inhibitor | 0.173 0.032 CID_2201 | CID_2201 | |
| 0.103 | 0.028 | 0.252 | Glutamate decarboxylase inhibitor | 0.252 0.004 CID_2201 | CID_2201 | |
| 0.09 | 0.017 | 0.1 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.1 0.014 CID_2201 | CID_2201 | |
| 0.099 | 0.026 | 0.29 | Phenylalanine 4-hydroxylase inhibitor | 0.29 0.004 CID_2201 | CID_2201 | |
| 0.142 | 0.069 | 0.142 | Pregnane X receptor agonist | 0.137 0.08 CID_2201 | ||
| 0.091 | 0.019 | 0.091 | 5 Hydroxytryptamine 3 agonist | |||
| 0.17 | 0.098 | 0.195 | Clk dual-specificity kinase inhibitor | 0.195 0.082 CID_2201 | CID_2201 | |
| 0.088 | 0.017 | 0.088 | Exportin-1 inhibitor | 0.082 0.023 CID_2201 | ||
| 0.157 | 0.086 | 0.203 | Neurotensin receptor agonist | 0.203 0.033 CID_2201 | CID_2201 | |
| 0.094 | 0.025 | 0.094 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.144 | 0.075 | 0.164 | Thiol protease inhibitor | 0.164 0.058 CID_2201 | CID_2201 | |
| 0.099 | 0.029 | 0.099 | Acetylcholine M4 receptor antagonist | 0.065 0.064 CID_2201 | ||
| 0.088 | 0.019 | 0.114 | Glutamate (mGluR7) antagonist | 0.114 0.005 CID_2201 | CID_2201 | |
| 0.073 | 0.005 | 0.073 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.104 | 0.036 | 0.148 | Glutamate release inhibitor | 0.148 0.01 CID_2201 | CID_2201 | |
| 0.083 | 0.015 | 0.083 | Botulinum neurotoxin type A inhibitor | |||
| 0.088 | 0.021 | 0.088 | Protein kinase C beta inhibitor | 0.081 0.028 CID_2201 | ||
| 0.123 | 0.056 | 0.133 | Caspase 3 inhibitor | 0.133 0.043 CID_2201 | CID_2201 | |
| 0.137 | 0.07 | 0.137 | Alkaline phosphatase inhibitor | 0.135 0.071 CID_2201 | ||
| 0.073 | 0.008 | 0.073 | Purinergic P2X4 antagonist | 0.044 0.035 CID_2201 | ||
| 0.101 | 0.037 | 0.148 | Carbonic anhydrase XIII inhibitor | 0.148 0.022 CID_2201 | CID_2201 | |
| 0.09 | 0.026 | 0.094 | HIV-1 integrase (Strand Transfer) inhibitor | 0.094 0.025 CID_2201 | CID_2201 | |
| 0.098 | 0.034 | 0.098 | Na+ K+ transporting ATPase inhibitor | 0.084 0.047 CID_2201 | ||
| 0.133 | 0.069 | 0.133 | Tubulin antagonist | |||
| 0.072 | 0.008 | 0.086 | Kainate receptor 2 antagonist | 0.086 0.005 CID_2201 | CID_2201 | |
| 0.085 | 0.022 | 0.138 | Xanthine dehydrogenase inhibitor | 0.138 0.008 CID_2201 | CID_2201 | |
| 0.204 | 0.142 | 0.315 | Gastrin inhibitor | 0.315 0.024 CID_2201 | CID_2201 | |
| 0.085 | 0.024 | 0.273 | Biliverdin reductase inhibitor | 0.273 0.004 CID_2201 | CID_2201 | |
| 0.08 | 0.018 | 0.08 | Fibroblast growth factor 4 antagonist | |||
| 0.109 | 0.047 | 0.12 | Prolactin inhibitor | 0.12 0.038 CID_2201 | CID_2201 | |
| 0.15 | 0.09 | 0.394 | Mcl-1 antagonist | 0.394 0.011 CID_2201 | CID_2201 | |
| 0.071 | 0.012 | 0.083 | Glucose-6-phosphate isomerase inhibitor | 0.083 0.008 CID_2201 | CID_2201 | |
| 0.112 | 0.053 | 0.311 | Carbonic anhydrase XV inhibitor | 0.311 0.007 CID_2201 | CID_2201 | |
| 0.094 | 0.036 | 0.094 | Nicotinic alpha4beta2 receptor antagonist | 0.09 0.04 CID_2201 | ||
| 0.185 | 0.127 | 0.185 | Antioxidant | 0.165 0.147 CID_2201 | ||
| 0.132 | 0.075 | 0.132 | Toll-Like receptor 9 antagonist | |||
| 0.08 | 0.024 | 0.159 | Glutamate (mGluR6) antagonist | 0.159 0.004 CID_2201 | CID_2201 | |
| 0.084 | 0.029 | 0.122 | Peroxisome proliferator-activated receptor gamma antagonist | 0.122 0.009 CID_2201 | CID_2201 | |
| 0.084 | 0.03 | 0.093 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.093 0.019 CID_2201 | CID_2201 | |
| 0.08 | 0.025 | 0.202 | Argininosuccinate synthase inhibitor | 0.202 0.008 CID_2201 | CID_2201 | |
| 0.121 | 0.067 | 0.121 | Alkylator | 0.115 0.073 CID_2201 | ||
| 0.105 | 0.051 | 0.217 | Electrolyte absorption antagonist | 0.217 0.006 CID_2201 | CID_2201 | |
| 0.142 | 0.088 | 0.269 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.269 0.005 CID_2201 | CID_2201 | |
| 0.064 | 0.01 | 0.064 | GABA B receptor antagonist | 0.049 0.02 CID_2201 | ||
| 0.105 | 0.051 | 0.122 | Interleukin 1 beta converting enzyme inhibitor | 0.122 0.033 CID_2201 | CID_2201 | |
| 0.094 | 0.041 | 0.23 | Catalase inhibitor | 0.23 0.011 CID_2201 | CID_2201 | |
| 0.206 | 0.153 | 0.234 | Prostaglandin dehydrogenase inhibitor | 0.234 0.136 CID_2201 | CID_2201 | |
| 0.124 | 0.072 | 0.124 | MAO inhibitor | |||
| 0.08 | 0.028 | 0.124 | Carbamoyl phosphate synthetase inhibitor | 0.124 0.015 CID_2201 | CID_2201 | |
| 0.059 | 0.007 | 0.073 | Angiotensin AT1 receptor antagonist | 0.073 0.004 CID_2201 | CID_2201 | |
| 0.063 | 0.012 | 0.112 | Glutamate (mGluR4) antagonist | 0.112 0.005 CID_2201 | CID_2201 | |
| 0.159 | 0.109 | 0.159 | Death-associated protein kinase 3 inhibitor | 0.143 0.134 CID_2201 | ||
| 0.109 | 0.059 | 0.207 | Aminopeptidase B inhibitor | 0.207 0.02 CID_2201 | CID_2201 | |
| 0.059 | 0.009 | 0.059 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.03 0.025 CID_2201 | ||
| 0.058 | 0.008 | 0.058 | Melatonin 2 agonist | |||
| 0.073 | 0.023 | 0.087 | Potassium channel intermediate-conductance Ca-activated blocker | 0.087 0.014 CID_2201 | CID_2201 | |
| 0.12 | 0.071 | 0.15 | DNA repair enzyme inhibitor | 0.15 0.032 CID_2201 | CID_2201 | |
| 0.063 | 0.014 | 0.063 | Progesterone antagonist | |||
| 0.063 | 0.016 | 0.066 | Adenylate cyclase 1 inhibitor | 0.066 0.014 CID_2201 | CID_2201 | |
| 0.161 | 0.114 | 0.161 | Focal adhesion kinase 2 inhibitor | |||
| 0.09 | 0.043 | 0.123 | Glycine receptor antagonist | 0.123 0.016 CID_2201 | CID_2201 | |
| 0.081 | 0.034 | 0.081 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.066 | 0.019 | 0.066 | Prolyl endopeptidase inhibitor | 0.046 0.042 CID_2201 | ||
| 0.059 | 0.014 | 0.123 | Glutamate (mGluR group III) antagonist | 0.123 0.004 CID_2201 | CID_2201 | |
| 0.144 | 0.1 | 0.144 | Nitric oxide antagonist | |||
| 0.113 | 0.069 | 0.137 | Microtubule formation inhibitor | 0.137 0.045 CID_2201 | CID_2201 | |
| 0.103 | 0.058 | 0.103 | MAO B inhibitor | |||
| 0.063 | 0.019 | 0.071 | Immunoglobulin Fc receptor antagonist | 0.071 0.01 CID_2201 | CID_2201 | |
| 0.101 | 0.058 | 0.126 | Sphingomyelinase inhibitor | 0.126 0.037 CID_2201 | CID_2201 | |
| 0.104 | 0.061 | 0.115 | Factor V inhibitor | 0.115 0.045 CID_2201 | CID_2201 | |
| 0.148 | 0.105 | 0.205 | ATPase inhibitor | 0.205 0.033 CID_2201 | CID_2201 | |
| 0.122 | 0.08 | 0.235 | Amylase inhibitor | 0.235 0.033 CID_2201 | CID_2201 | |
| 0.082 | 0.04 | 0.156 | Aminopeptidase I inhibitor | 0.156 0.012 CID_2201 | CID_2201 | |
| 0.045 | 0.003 | 0.045 | Complement factor 1s inhibitor | 0.03 0.008 CID_2201 | ||
| 0.048 | 0.008 | 0.084 | Angiotensin II receptor antagonist | 0.084 0.004 CID_2201 | CID_2201 | |
| 0.068 | 0.028 | 0.185 | Acyl-CoA dehydrogenase inhibitor | 0.185 0.006 CID_2201 | CID_2201 | |
| 0.078 | 0.037 | 0.094 | Phospholipase D inhibitor | 0.094 0.018 CID_2201 | CID_2201 | |
| 0.054 | 0.014 | 0.054 | Alpha 1d adrenoreceptor agonist | 0.04 0.026 CID_2201 | ||
| 0.064 | 0.025 | 0.207 | Dihydroorotate dehydrogenase inhibitor | 0.207 0.004 CID_2201 | CID_2201 | |
| 0.062 | 0.024 | 0.079 | Nicotinic alpha3beta2 receptor antagonist | 0.079 0.013 CID_2201 | CID_2201 | |
| 0.056 | 0.018 | 0.1 | Kainate receptor antagonist | 0.1 0.007 CID_2201 | CID_2201 | |
| 0.048 | 0.011 | 0.048 | Calcium release-activated channel blocker | |||
| 0.052 | 0.014 | 0.052 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.165 | 0.128 | 0.332 | Cyclic AMP phosphodiesterase inhibitor | 0.332 0.031 CID_2201 | CID_2201 | |
| 0.056 | 0.019 | 0.339 | Dihydroorotase inhibitor | 0.339 0.002 CID_2201 | CID_2201 | |
| 0.052 | 0.016 | 0.081 | Nerve growth factor antagonist | 0.081 0.004 CID_2201 | CID_2201 | |
| 0.086 | 0.05 | 0.098 | Estrogen-related receptor beta agonist | 0.098 0.027 CID_2201 | CID_2201 | |
| 0.054 | 0.019 | 0.054 | DNA-dependent protein kinase inhibitor | |||
| 0.043 | 0.009 | 0.043 | Kainate receptor 4 antagonist | |||
| 0.184 | 0.15 | 0.184 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.131 | 0.097 | 0.131 | Heat shock protein 90 antagonist | |||
| 0.049 | 0.016 | 0.113 | GABA uptake inhibitor | 0.113 0.003 CID_2201 | CID_2201 | |
| 0.076 | 0.044 | 0.153 | Glycine receptor agonist | 0.153 0.006 CID_2201 | CID_2201 | |
| 0.066 | 0.034 | 0.066 | Glutamate (mGluR1) antagonist | 0.061 0.038 CID_2201 | ||
| 0.048 | 0.017 | 0.048 | Estradiol 17 beta-dehydrogenase 2 inhibitor | |||
| 0.078 | 0.047 | 0.122 | GABA B receptor agonist | 0.122 0.007 CID_2201 | CID_2201 | |
| 0.049 | 0.018 | 0.055 | Dopamine D5 agonist | 0.055 0.014 CID_2201 | CID_2201 | |
| 0.063 | 0.032 | 0.063 | Bcl-xL inhibitor | 0.062 0.035 CID_2201 | ||
| 0.1 | 0.07 | 0.172 | AMP-activated protein kinase stimulant | 0.172 0.017 CID_2201 | CID_2201 | |
| 0.088 | 0.059 | 0.091 | Bromodomain-containing protein 2 inhibitor | 0.091 0.053 CID_2201 | CID_2201 | |
| 0.068 | 0.04 | 0.094 | CDC25B inhibitor | 0.094 0.018 CID_2201 | CID_2201 | |
| 0.032 | 0.005 | 0.032 | Alpha 2a adrenoreceptor agonist | |||
| 0.05 | 0.025 | 0.05 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.053 | 0.029 | 0.082 | Phosphorylase inhibitor | 0.082 0.016 CID_2201 | CID_2201 | |
| 0.05 | 0.027 | 0.05 | Benzodiazepine antagonist | |||
| 0.128 | 0.105 | 0.14 | Cyclin-dependent kinase 8 inhibitor | 0.14 0.09 CID_2201 | CID_2201 | |
| 0.075 | 0.052 | 0.075 | Vanilloid 4 agonist | 0.075 0.051 CID_2201 | ||
| 0.057 | 0.034 | 0.057 | Pim-2 kinase inhibitor | |||
| 0.028 | 0.005 | 0.028 | Alpha 2c adrenoreceptor agonist | |||
| 0.142 | 0.119 | 0.155 | Hepatoprotectant | 0.155 0.104 CID_2201 | CID_2201 | |
| 0.095 | 0.072 | 0.106 | Glutamate (mGluR7) agonist | 0.106 0.049 CID_2201 | CID_2201 | |
| 0.051 | 0.028 | 0.051 | Cholesterol esterase inhibitor | |||
| 0.104 | 0.082 | 0.112 | Proteasome inhibitor | 0.112 0.073 CID_2201 | CID_2201 | |
| 0.084 | 0.062 | 0.128 | Histamine N-methyltransferase inhibitor | 0.128 0.024 CID_2201 | CID_2201 | |
| 0.039 | 0.017 | 0.039 | Purinergic P2X3 antagonist | |||
| 0.182 | 0.16 | 0.259 | Lipoxygenase inhibitor | 0.259 0.094 CID_2201 | CID_2201 | |
| 0.026 | 0.004 | 0.026 | Granulocyte colony stimulating factor receptor agonist | |||
| 0.043 | 0.022 | 0.085 | AMPA 4 receptor antagonist | 0.085 0.006 CID_2201 | CID_2201 | |
| 0.036 | 0.015 | 0.051 | Glutamate (mGluR3) agonist | 0.051 0.005 CID_2201 | CID_2201 | |
| 0.041 | 0.021 | 0.081 | Glutamate (mGluR8) agonist | 0.081 0.004 CID_2201 | CID_2201 | |
| 0.08 | 0.061 | 0.08 | Thioredoxin reductase inhibitor | |||
| 0.028 | 0.008 | 0.028 | Imidazoline I1 receptor antagonist | |||
| 0.038 | 0.019 | 0.059 | Tryptophan 5 hydroxylase inhibitor | 0.059 0.004 CID_2201 | CID_2201 | |
| 0.042 | 0.023 | 0.064 | 5-Alpha-reductase inhibitor | 0.064 0.015 CID_2201 | CID_2201 | |
| 0.043 | 0.025 | 0.098 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.098 0.003 CID_2201 | CID_2201 | |
| 0.081 | 0.062 | 0.081 | CC chemokine 5 receptor agonist | |||
| 0.039 | 0.022 | 0.114 | Nicotinic acid receptor agonist | 0.114 0.004 CID_2201 | CID_2201 | |
| 0.036 | 0.019 | 0.037 | Melatonin receptor 1A agonist | 0.037 0.017 CID_2201 | CID_2201 | |
| 0.038 | 0.021 | 0.149 | Retinoid X alpha receptor agonist | 0.149 0.003 CID_2201 | CID_2201 | |
| 0.035 | 0.018 | 0.035 | Methionyl aminopeptidase 1 inhibitor | 0.031 0.024 CID_2201 | ||
| 0.026 | 0.009 | 0.026 | Inosine monophosphate dehydrogenase 2 inhibitor | |||
| 0.055 | 0.039 | 0.092 | Dihydroorotate oxidase inhibitor | 0.092 0.006 CID_2201 | CID_2201 | |
| 0.039 | 0.023 | 0.126 | Retinoid X receptor agonist | 0.126 0.003 CID_2201 | CID_2201 | |
| 0.051 | 0.035 | 0.073 | Thromboxane A2 antagonist | 0.073 0.019 CID_2201 | CID_2201 | |
| 0.063 | 0.047 | 0.063 | Aryl hydrocarbon receptor antagonist | |||
| 0.047 | 0.032 | 0.047 | Potassium channel Kv1.3 blocker | |||
| 0.026 | 0.011 | 0.034 | Kainate receptor 5 antagonist | 0.034 0.008 CID_2201 | CID_2201 | |
| 0.086 | 0.071 | 0.33 | Uric acid excretion stimulant | 0.33 0.005 CID_2201 | CID_2201 | |
| 0.125 | 0.11 | 0.263 | Hexokinase inhibitor | 0.263 0.015 CID_2201 | CID_2201 | |
| 0.039 | 0.024 | 0.076 | Retinoid X receptor antagonist | 0.076 0.003 CID_2201 | CID_2201 | |
| 0.05 | 0.036 | 0.05 | Potassium channel (Inward rectifier) activator | |||
| 0.022 | 0.008 | 0.022 | Alpha 2b adrenoreceptor agonist | |||
| 0.041 | 0.028 | 0.071 | Kainate receptor agonist | 0.071 0.004 CID_2201 | CID_2201 | |
| 0.048 | 0.034 | 0.048 | Potassium channel (ATP-sensitive) activator | |||
| 0.053 | 0.039 | 0.053 | Nicotinic alpha7 receptor agonist | |||
| 0.034 | 0.021 | 0.047 | Protein kinase (CK2) beta inhibitor | 0.047 0.008 CID_2201 | CID_2201 | |
| 0.062 | 0.049 | 0.062 | Transcription factor RelA inhibitor | 0.061 0.051 CID_2201 | ||
| 0.035 | 0.022 | 0.066 | Retinoid X alpha receptor antagonist | 0.066 0.003 CID_2201 | CID_2201 | |
| 0.025 | 0.012 | 0.046 | Glutamate (mGluR1a) agonist | 0.046 0.005 CID_2201 | CID_2201 | |
| 0.045 | 0.032 | 0.045 | Oleamide hydrolase inhibitor | |||
| 0.03 | 0.018 | 0.038 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.038 0.013 CID_2201 | CID_2201 | |
| 0.035 | 0.023 | 0.119 | Fumarate hydratase inhibitor | 0.119 0.004 CID_2201 | CID_2201 | |
| 0.08 | 0.068 | 0.091 | mTOR complex 2 inhibitor | 0.091 0.045 CID_2201 | CID_2201 | |
| 0.054 | 0.043 | 0.071 | Sphingosine 1-phosphate receptor 1 antagonist | 0.071 0.018 CID_2201 | CID_2201 | |
| 0.024 | 0.013 | 0.049 | Kainate receptor 1 antagonist | 0.049 0.005 CID_2201 | CID_2201 | |
| 0.15 | 0.14 | 0.15 | Growth factor agonist | |||
| 0.054 | 0.044 | 0.077 | Fatty acid synthase inhibitor | 0.077 0.02 CID_2201 | CID_2201 | |
| 0.162 | 0.152 | 0.196 | Spasmolytic | 0.196 0.123 CID_2201 | CID_2201 | |
| 0.022 | 0.012 | 0.048 | Retinoid X beta receptor antagonist | 0.048 0.003 CID_2201 | CID_2201 | |
| 0.035 | 0.026 | 0.035 | AMPA receptor agonist | 0.035 0.025 CID_2201 | ||
| 0.056 | 0.047 | 0.067 | Androgen agonist | 0.067 0.033 CID_2201 | CID_2201 | |
| 0.049 | 0.04 | 0.113 | Ornithine carbamoyltransferase inhibitor | 0.113 0.014 CID_2201 | CID_2201 | |
| 0.042 | 0.034 | 0.042 | Heme oxygenase inhibitor | 0.042 0.033 CID_2201 | ||
| 0.05 | 0.042 | 0.079 | Thromboxane antagonist | 0.079 0.021 CID_2201 | CID_2201 | |
| 0.037 | 0.03 | 0.039 | Vanilloid 3 antagonist | 0.039 0.023 CID_2201 | CID_2201 | |
| 0.028 | 0.021 | 0.045 | AMPA 1 receptor antagonist | 0.045 0.013 CID_2201 | CID_2201 | |
| 0.089 | 0.082 | 0.131 | Falcipain 3 inhibitor | 0.131 0.047 CID_2201 | CID_2201 | |
| 0.036 | 0.029 | 0.105 | TRPM8 blocker | 0.105 0.006 CID_2201 | CID_2201 | |
| 0.039 | 0.032 | 0.039 | Phenylethanolamine N methyltransferase inhibitor | |||
| 0.016 | 0.01 | 0.016 | Antibiotic Tetracycline-like | |||
| 0.071 | 0.066 | 0.071 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | |||
| 0.042 | 0.036 | 0.042 | Histamine H1 receptor agonist | |||
| 0.016 | 0.01 | 0.016 | Purinergic P2Y1 agonist | |||
| 0.019 | 0.014 | 0.028 | 5-Alpha-reductase 2 inhibitor | 0.028 0.009 CID_2201 | CID_2201 | |
| 0.024 | 0.02 | 0.039 | Lysophosphatidic acid receptor 1 agonist | 0.039 0.006 CID_2201 | CID_2201 | |
| 0.082 | 0.078 | 0.082 | MAO A inhibitor | |||
| 0.022 | 0.018 | 0.022 | ICAM 1 antagonist | |||
| 0.027 | 0.023 | 0.028 | Purinergic P2Y15 antagonist | 0.028 0.022 CID_2201 | CID_2201 | |
| 0.013 | 0.009 | 0.013 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.013 0.01 CID_2201 | ||
| 0.015 | 0.011 | 0.018 | Thromboxane A2 agonist | 0.018 0.007 CID_2201 | CID_2201 | |
| 0.051 | 0.048 | 0.101 | DNA helicase inhibitor | 0.101 0.005 CID_2201 | CID_2201 | |
| 0.013 | 0.01 | 0.026 | Angiotensin AT1B receptor antagonist | 0.026 0.004 CID_2201 | CID_2201 | |
| 0.034 | 0.031 | 0.034 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.039 | 0.037 | 0.051 | Purinergic P2Y antagonist | 0.051 0.026 CID_2201 | CID_2201 | |
| 0.026 | 0.024 | 0.052 | AMPA 3 receptor antagonist | 0.052 0.008 CID_2201 | CID_2201 | |
| 0.01 | 0.009 | 0.01 | Imidazoline I2 receptor antagonist | |||
| 0.048 | 0.047 | 0.061 | Alpha-mannosidase inhibitor | 0.061 0.026 CID_2201 | CID_2201 | |
| 0.071 | 0.07 | 0.071 | Acetylcholine nicotinic agonist | |||
| 0.038 | 0.037 | 0.071 | Guanylate cyclase inhibitor | 0.071 0.005 CID_2201 | CID_2201 | |
| 0.026 | 0.025 | 0.027 | Hedgehog signaling activator | 0.027 0.019 CID_2201 | CID_2201 | |
| 0.07 | 0.07 | 0.091 | Sphingosine 1-phosphate receptor antagonist | 0.091 0.029 CID_2201 | CID_2201 | |
| 0.036 | 0.036 | 0.039 | Glutamate (mGluR1a) antagonist | 0.039 0.031 CID_2201 | CID_2201 | |
| 0.039 | 0.039 | 0.065 | Geranyltranstransferase inhibitor | 0.065 0.01 CID_2201 | CID_2201 | |
| 0.04 | 0.041 | 0.057 | Thymidylate synthase inhibitor | 0.057 0.02 CID_2201 | CID_2201 | |
| 0.024 | 0.025 | 0.06 | Nicotinic acid receptor 2 antagonist | 0.06 0.003 CID_2201 | CID_2201 | |
| 0.017 | 0.019 | 0.021 | Antibiotic Anthracycline-like | 0.021 0.009 CID_2201 | CID_2201 | |
| 0.044 | 0.046 | 0.053 | Dopamine beta hydroxylase inhibitor | 0.053 0.025 CID_2201 | CID_2201 | |
| 0.024 | 0.027 | 0.027 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.027 0.018 CID_2201 | CID_2201 | |
| 0.016 | 0.019 | 0.022 | Methylmalonyl-CoA mutase inhibitor | 0.022 0.006 CID_2201 | CID_2201 | |
| 0.032 | 0.035 | 0.155 | Glutamate (mGluR3) antagonist | 0.155 0.004 CID_2201 | CID_2201 | |
| 0.07 | 0.073 | 0.119 | Calcium antagonist | 0.119 0.036 CID_2201 | CID_2201 | |
| 0.013 | 0.016 | 0.022 | 5-Alpha-reductase 1 inhibitor | 0.022 0.01 CID_2201 | CID_2201 | |
| 0.015 | 0.018 | 0.025 | Peroxisome proliferator-activated receptor alpha antagonist | 0.025 0.014 CID_2201 | CID_2201 | |
| 0.048 | 0.052 | 0.055 | Sphingosine kinase 2 inhibitor | 0.055 0.039 CID_2201 | CID_2201 | |
| 0.082 | 0.085 | 0.108 | MAP kinase kinase 1 inhibitor | 0.108 0.048 CID_2201 | CID_2201 | |
| 0.128 | 0.132 | 0.224 | DNA methyltransferase I inhibitor | 0.224 0.058 CID_2201 | CID_2201 | |
| 0.022 | 0.026 | 0.034 | Vanilloid 2 agonist | 0.034 0.006 CID_2201 | CID_2201 | |
| 0.046 | 0.05 | 0.054 | Protein kinase C eta inhibitor | 0.054 0.039 CID_2201 | CID_2201 | |
| 0.038 | 0.042 | 0.063 | AICAR transformylase inhibitor | 0.063 0.013 CID_2201 | CID_2201 | |
| 0.018 | 0.023 | 0.02 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.02 0.018 CID_2201 | CID_2201 | |
| 0.024 | 0.028 | 0.03 | LFA antagonist | 0.03 0.016 CID_2201 | CID_2201 | |
| 0.095 | 0.1 | 0.102 | Acetylcholine release stimulant | 0.102 0.083 CID_2201 | CID_2201 | |
| 0.028 | 0.034 | 0.061 | Free fatty acid receptor 1 antagonist | 0.061 0.005 CID_2201 | CID_2201 | |
| 0.059 | 0.064 | 0.067 | Calcium channel P-type blocker | 0.067 0.034 CID_2201 | CID_2201 | |
| 0.043 | 0.049 | 0.083 | Lysophosphatidic acid 3 receptor antagonist | 0.083 0.008 CID_2201 | CID_2201 | |
| 0.027 | 0.033 | 0.058 | ATP citrate lysase inhibitor | 0.058 0.005 CID_2201 | CID_2201 | |
| 0.009 | 0.016 | 0.018 | Lysophosphatidic acid receptor 3 agonist | 0.018 0.006 CID_2201 | CID_2201 | |
| 0.061 | 0.068 | 0.106 | Cathepsin G inhibitor | 0.106 0.031 CID_2201 | CID_2201 | |
| 0.119 | 0.127 | 0.197 | Sphingosine 1-phosphate receptor 5 antagonist | 0.197 0.012 CID_2201 | CID_2201 | |
| 0.014 | 0.022 | 0.017 | Telomerase stimulant | 0.017 0.013 CID_2201 | CID_2201 | |
| 0.091 | 0.1 | 0.187 | Cholesterol synthesis inhibitor | 0.187 0.03 CID_2201 | CID_2201 | |
| 0.031 | 0.04 | 0.113 | Urate transporter 1 inhibitor | 0.113 0.005 CID_2201 | CID_2201 | |
| 0.017 | 0.026 | 0.02 | Geranylgeranyltransferase inhibitor | 0.02 0.019 CID_2201 | CID_2201 | |
| 0.018 | 0.027 | 0.061 | Methionyl aminopeptidase 2 inhibitor | 0.061 0.005 CID_2201 | CID_2201 | |
| 0.03 | 0.039 | 0.036 | Ceramide glucosyltransferase inhibitor | 0.036 0.024 CID_2201 | CID_2201 | |
| 0.046 | 0.055 | 0.086 | Leukotriene B4 antagonist | 0.086 0.013 CID_2201 | CID_2201 | |
| 0.063 | 0.072 | 0.137 | Glutamate receptor agonist | 0.137 0.021 CID_2201 | CID_2201 | |
| 0.012 | 0.021 | 0.026 | Carbonic anhydrase X inhibitor | 0.026 0.005 CID_2201 | CID_2201 | |
| 0.012 | 0.021 | 0.026 | Carbonic anhydrase VIII inhibitor | 0.026 0.005 CID_2201 | CID_2201 | |
| 0.017 | 0.027 | 0.028 | Protease (Human cytomegalovirus) inhibitor | 0.028 0.009 CID_2201 | CID_2201 | |
| 0.07 | 0.081 | 0.09 | MAP kinase kinase 7 inhibitor | 0.09 0.024 CID_2201 | CID_2201 | |
| 0.03 | 0.042 | 0.038 | Calcium-independent phospholipase A2 inhibitor | 0.038 0.014 CID_2201 | CID_2201 | |
| 0.048 | 0.061 | 0.069 | Sphingosine 1-phosphate receptor 3 antagonist | 0.069 0.026 CID_2201 | CID_2201 | |
| 0.096 | 0.109 | 0.111 | Glycogen synthase kinase-3 alpha inhibitor | 0.111 0.092 CID_2201 | CID_2201 | |
| 0.016 | 0.03 | 0.058 | NMDA receptor glycine site antagonist | 0.058 0.005 CID_2201 | CID_2201 | |
| 0.01 | 0.024 | 0.028 | G-protein-coupled receptor 120 agonist | 0.028 0.005 CID_2201 | CID_2201 | |
| 0.022 | 0.035 | 0.025 | Thymidine phosphorylase inhibitor | 0.025 0.021 CID_2201 | CID_2201 | |
| 0.009 | 0.022 | 0.019 | Human herpes virus 5 capsid protein P40 inhibitor | 0.019 0.005 CID_2201 | CID_2201 | |
| 0.017 | 0.031 | 0.025 | Angiotensin AT1A receptor antagonist | 0.025 0.009 CID_2201 | CID_2201 | |
| 0.183 | 0.198 | 0.301 | Vasodilator, coronary | 0.301 0.087 CID_2201 | CID_2201 | |
| 0.035 | 0.05 | 0.058 | Mannosidase inhibitor | 0.058 0.018 CID_2201 | CID_2201 | |
| 0.019 | 0.035 | 0.038 | Glutamate (mGluR1) agonist | 0.038 0.006 CID_2201 | CID_2201 | |
| 0.012 | 0.028 | 0.041 | Nicotinic acid receptor 1 antagonist | 0.041 0.003 CID_2201 | CID_2201 | |
| 0.007 | 0.024 | 0.022 | Glutamate (mGluR6) agonist | 0.022 0.004 CID_2201 | CID_2201 | |
| 0.049 | 0.067 | 0.059 | Sphingosine kinase inhibitor | 0.059 0.04 CID_2201 | CID_2201 | |
| 0.034 | 0.052 | 0.076 | Sphingosine 1-phosphate receptor agonist | 0.076 0.01 CID_2201 | CID_2201 | |
| 0.006 | 0.025 | 0.012 | Thromboxane agonist | 0.012 0.007 CID_2201 | CID_2201 | |
| 0.016 | 0.035 | 0.022 | Prostaglandin F2 alpha agonist | 0.022 0.016 CID_2201 | CID_2201 | |
| 0.007 | 0.027 | 0.029 | Egl nine homolog 3 inhibitor | 0.029 0.004 CID_2201 | CID_2201 | |
| 0.045 | 0.065 | 0.063 | Carbonic anhydrase stimulant | 0.063 0.038 CID_2201 | CID_2201 | |
| 0.024 | 0.044 | 0.046 | Phosphoglycerate kinase inhibitor | 0.046 0.015 CID_2201 | CID_2201 | |
| 0.007 | 0.028 | 0.012 | Carbonic anhydrase XI inhibitor | 0.012 0.009 CID_2201 | CID_2201 | |
| 0.017 | 0.038 | 0.046 | Uridine phosphorylase inhibitor | 0.046 0.009 CID_2201 | CID_2201 | |
| 0.06 | 0.081 | 0.09 | MDM2 inhibitor | 0.09 0.011 CID_2201 | CID_2201 | |
| 0.062 | 0.084 | 0.193 | Keratolytic | 0.193 0.009 CID_2201 | CID_2201 | |
| 0.026 | 0.048 | 0.037 | Diamine oxidase inhibitor | 0.037 0.026 CID_2201 | CID_2201 | |
| 0.02 | 0.042 | 0.041 | Integrin alpha2beta1 antagonist | 0.041 0.006 CID_2201 | CID_2201 | |
| 0.077 | 0.099 | 0.203 | Carbonic anhydrase III inhibitor | 0.203 0.016 CID_2201 | CID_2201 | |
| 0.028 | 0.051 | 0.054 | Integrin alpha2 antagonist | 0.054 0.009 CID_2201 | CID_2201 | |
| 0.168 | 0.191 | 0.238 | Transcription factor STAT inhibitor | 0.238 0.095 CID_2201 | CID_2201 | |
| 0.038 | 0.061 | 0.087 | Diacylglycerol O-acyltransferase inhibitor | 0.087 0.011 CID_2201 | CID_2201 | |
| 0.016 | 0.04 | 0.022 | Isoleucine-tRNA ligase inhibitor | 0.022 0.016 CID_2201 | CID_2201 | |
| 0.166 | 0.191 | 0.185 | Neuropeptide Y2 antagonist | 0.185 0.149 CID_2201 | CID_2201 | |
| 0.017 | 0.042 | 0.055 | Liver X receptor beta antagonist | 0.055 0.007 CID_2201 | CID_2201 | |
| 0.039 | 0.064 | 0.047 | HCV NS3/NS4A protease inhibitor | 0.047 0.039 CID_2201 | CID_2201 | |
| 0.016 | 0.041 | 0.024 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.024 0.015 CID_2201 | CID_2201 | |
| 0.117 | 0.143 | 0.21 | Dual specificity phosphatase inhibitor | 0.21 0.05 CID_2201 | CID_2201 | |
| 0.018 | 0.045 | 0.057 | Calcium-sensing receptor agonist | 0.057 0.005 CID_2201 | CID_2201 | |
| 0.028 | 0.055 | 0.053 | Membrane dipeptidase inhibitor | 0.053 0.014 CID_2201 | CID_2201 | |
| 0.042 | 0.068 | 0.1 | Factor III inhibitor | 0.1 0.005 CID_2201 | CID_2201 | |
| 0.05 | 0.079 | 0.07 | Ryanodine receptor antagonist | 0.07 0.017 CID_2201 | CID_2201 | |
| 0.042 | 0.07 | 0.074 | Heparanase inhibitor | 0.074 0.009 CID_2201 | CID_2201 | |
| 0.066 | 0.094 | 0.109 | Glutathione S-transferase inhibitor | 0.109 0.029 CID_2201 | CID_2201 | |
| 0.042 | 0.071 | 0.12 | NMDA receptor glycine site agonist | 0.12 0.009 CID_2201 | CID_2201 | |
| 0.013 | 0.043 | 0.04 | Leukotriene B4 receptor 2 antagonist | 0.04 0.005 CID_2201 | CID_2201 | |
| 0.078 | 0.107 | 0.129 | Bile acid receptor antagonist | 0.129 0.013 CID_2201 | CID_2201 | |
| 0.021 | 0.051 | 0.032 | Epoxide hydrolase 1 inhibitor | 0.032 0.019 CID_2201 | CID_2201 | |
| 0.029 | 0.059 | 0.068 | Adenosine deaminase inhibitor | 0.068 0.014 CID_2201 | CID_2201 | |
| 0.079 | 0.111 | 0.101 | Phosphodiesterase 6D inhibitor | 0.101 0.05 CID_2201 | CID_2201 | |
| 0.014 | 0.045 | 0.04 | Lysophosphatidic acid 1 receptor antagonist | 0.04 0.004 CID_2201 | CID_2201 | |
| 0.012 | 0.044 | 0.019 | CXC chemokine 5 receptor antagonist | 0.019 0.01 CID_2201 | CID_2201 | |
| 0.015 | 0.048 | 0.028 | Lysine carboxypeptidase inhibitor | 0.028 0.017 CID_2201 | CID_2201 | |
| 0.048 | 0.08 | 0.071 | Leukotriene C antagonist | 0.071 0.013 CID_2201 | CID_2201 | |
| 0.033 | 0.065 | 0.046 | Dihydrofolate reductase inhibitor | 0.046 0.025 CID_2201 | CID_2201 | |
| 0.061 | 0.093 | 0.154 | Carbonic anhydrase VI inhibitor | 0.154 0.02 CID_2201 | CID_2201 | |
| 0.01 | 0.043 | 0.051 | Prostaglandin EP2 agonist | 0.051 0.005 CID_2201 | CID_2201 | |
| 0.011 | 0.044 | 0.042 | Prostaglandin H2 antagonist | 0.042 0.005 CID_2201 | CID_2201 | |
| 0.011 | 0.044 | 0.036 | Prostaglandin E2 agonist | 0.036 0.008 CID_2201 | CID_2201 | |
| 0.008 | 0.041 | 0.017 | Aminopeptidase A inhibitor | 0.017 0.013 CID_2201 | CID_2201 | |
| 0.141 | 0.175 | 0.308 | Interleukin agonist | 0.308 0.044 CID_2201 | CID_2201 | |
| 0.066 | 0.101 | 0.079 | Caspase 7 inhibitor | 0.079 0.064 CID_2201 | CID_2201 | |
| 0.033 | 0.068 | 0.045 | CF transmembrane conductance regulator antagonist | 0.045 0.014 CID_2201 | CID_2201 | |
| 0.122 | 0.157 | 0.241 | I kappa B kinase epsilon inhibitor | 0.241 0.042 CID_2201 | CID_2201 | |
| 0.103 | 0.138 | 0.288 | Protein-tyrosine phosphatase inhibitor | 0.288 0.021 CID_2201 | CID_2201 | |
| 0.014 | 0.049 | 0.031 | Neuraminidase (Influenza B) inhibitor | 0.031 0.004 CID_2201 | CID_2201 | |
| 0.071 | 0.106 | 0.081 | 3C-Like protease (SARS coronavirus) inhibitor | 0.081 0.066 CID_2201 | CID_2201 | |
| 0.013 | 0.048 | 0.019 | Caspase 8 inhibitor | 0.019 0.015 CID_2201 | CID_2201 | |
| 0.034 | 0.07 | 0.051 | Aldosterone antagonist | 0.051 0.028 CID_2201 | CID_2201 | |
| 0.103 | 0.139 | 0.116 | Vanilloid 1 agonist | 0.116 0.098 CID_2201 | CID_2201 | |
| 0.048 | 0.085 | 0.094 | Prostaglandin-E synthase inhibitor | 0.094 0.03 CID_2201 | CID_2201 | |
| 0.017 | 0.054 | 0.048 | Prostaglandin agonist | 0.048 0.01 CID_2201 | CID_2201 | |
| 0.109 | 0.146 | 0.211 | Dual specificity phosphatase 3 inhibitor | 0.211 0.055 CID_2201 | CID_2201 | |
| 0.075 | 0.112 | 0.224 | Protein-tyrosine phosphatase 1B inhibitor | 0.224 0.023 CID_2201 | CID_2201 | |
| 0.023 | 0.06 | 0.091 | RNA-directed RNA polymerase inhibitor | 0.091 0.005 CID_2201 | CID_2201 | |
| 0.027 | 0.064 | 0.055 | Liver X receptor alpha agonist | 0.055 0.015 CID_2201 | CID_2201 | |
| 0.031 | 0.069 | 0.096 | Carbonic anhydrase VB inhibitor | 0.096 0.017 CID_2201 | CID_2201 | |
| 0.03 | 0.068 | 0.053 | Fructose-1,6-bisphosphatase inhibitor | 0.053 0.022 CID_2201 | CID_2201 | |
| 0.027 | 0.066 | 0.06 | Sphingosine 1-phosphate receptor 1 agonist | 0.06 0.013 CID_2201 | CID_2201 | |
| 0.044 | 0.083 | 0.095 | Leukotriene antagonist | 0.095 0.024 CID_2201 | CID_2201 | |
| 0.019 | 0.058 | 0.037 | Lysophosphatidic acid 2 receptor antagonist | 0.037 0.014 CID_2201 | CID_2201 | |
| 0.118 | 0.158 | 0.168 | MAP kinase kinase 4 inhibitor | 0.168 0.035 CID_2201 | CID_2201 | |
| 0.004 | 0.046 | 0.045 | Prostaglandin EP4 agonist | 0.045 0.005 CID_2201 | CID_2201 | |
| 0.066 | 0.108 | 0.116 | Urease inhibitor | 0.116 0.049 CID_2201 | CID_2201 | |
| 0.19 | 0.232 | 0.234 | DNA polymerase beta inhibitor | 0.234 0.202 CID_2201 | CID_2201 | |
| 0.019 | 0.061 | 0.039 | Cholesterol ester transfer protein antagonist | 0.039 0.013 CID_2201 | CID_2201 | |
| 0.026 | 0.069 | 0.156 | Retinoic acid alpha receptor agonist | 0.156 0.003 CID_2201 | CID_2201 | |
| 0.039 | 0.082 | 0.134 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.134 0.009 CID_2201 | CID_2201 | |
| 0.113 | 0.157 | 0.139 | MAP kinase 3 inhibitor | 0.139 0.086 CID_2201 | CID_2201 | |
| 0.031 | 0.074 | 0.048 | Leukotriene C4 antagonist | 0.048 0.012 CID_2201 | CID_2201 | |
| 0.018 | 0.062 | 0.043 | Glutamate (mGluR2) antagonist | 0.043 0.01 CID_2201 | CID_2201 | |
| 0.073 | 0.119 | 0.166 | Topoisomerase II inhibitor | 0.166 0.043 CID_2201 | CID_2201 | |
| 0.012 | 0.058 | 0.153 | Retinoic acid beta receptor agonist | 0.153 0.003 CID_2201 | CID_2201 | |
| 0.045 | 0.092 | 0.096 | Carbonic anhydrase VA inhibitor | 0.096 0.027 CID_2201 | CID_2201 | |
| 0.005 | 0.052 | 0.089 | Retinoic acid beta receptor antagonist | 0.089 0.003 CID_2201 | CID_2201 | |
| 0.011 | 0.058 | 0.061 | Kynurenine 3 monooxygenase inhibitor | 0.061 0.005 CID_2201 | CID_2201 | |
| 0.006 | 0.054 | 0.078 | Retinoic acid receptor gamma antagonist | 0.078 0.003 CID_2201 | CID_2201 | |
| 0.043 | 0.092 | 0.138 | NMDA receptor agonist | 0.138 0.01 CID_2201 | CID_2201 | |
| 0.022 | 0.071 | 0.067 | Glutamate (mGluR group II) antagonist | 0.067 0.009 CID_2201 | CID_2201 | |
| 0.005 | 0.056 | 0.014 | Thrombopoietin agonist | 0.014 0.005 CID_2201 | CID_2201 | |
| 0.012 | 0.063 | 0.025 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.025 0.022 CID_2201 | CID_2201 | |
| 0.013 | 0.065 | 0.075 | Prostaglandin EP4 antagonist | 0.075 0.005 CID_2201 | CID_2201 | |
| 0.043 | 0.095 | 0.068 | CDC7 inhibitor | 0.068 0.046 CID_2201 | CID_2201 | |
| 0.023 | 0.076 | 0.036 | Glutamate (mGluR4) agonist | 0.036 0.02 CID_2201 | CID_2201 | |
| 0.113 | 0.166 | 0.206 | DNA methylase inhibitor | 0.206 0.076 CID_2201 | CID_2201 | |
| 0.05 | 0.104 | 0.116 | HIV-1 integrase inhibitor | 0.116 0.017 CID_2201 | CID_2201 | |
| 0.012 | 0.065 | 0.056 | Arginase inhibitor | 0.056 0.012 CID_2201 | CID_2201 | |
| 0.021 | 0.075 | 0.054 | Dihydropteroate synthase inhibitor | 0.054 0.014 CID_2201 | CID_2201 | |
| 0.082 | 0.137 | 0.163 | Cyclooxygenase 3 inhibitor | 0.163 0.038 CID_2201 | CID_2201 | |
| 0.014 | 0.069 | 0.07 | HCV NS5B polymerase inhibitor | 0.07 0.007 CID_2201 | CID_2201 | |
| 0.009 | 0.065 | 0.084 | Retinoic acid alpha receptor antagonist | 0.084 0.003 CID_2201 | CID_2201 | |
| 0.029 | 0.086 | 0.153 | Plasminogen activator inhibitor antagonist | 0.153 0.005 CID_2201 | CID_2201 | |
| 0.069 | 0.126 | 0.09 | T cell inhibitor | 0.09 0.039 CID_2201 | CID_2201 | |
| 0.055 | 0.112 | 0.082 | Interferon agonist | 0.082 0.048 CID_2201 | CID_2201 | |
| 0.008 | 0.066 | 0.082 | Retinoic acid receptor antagonist | 0.082 0.003 CID_2201 | CID_2201 | |
| 0.007 | 0.066 | 0.027 | Angiotensin AT2 receptor antagonist | 0.027 0.014 CID_2201 | CID_2201 | |
| 0.059 | 0.117 | 0.194 | Protein kinase (CK2) inhibitor | 0.194 0.02 CID_2201 | CID_2201 | |
| 0.06 | 0.119 | 0.253 | Topoisomerase I inhibitor | 0.253 0.016 CID_2201 | CID_2201 | |
| 0.016 | 0.075 | 0.037 | Liver X receptor beta agonist | 0.037 0.018 CID_2201 | CID_2201 | |
| 0.102 | 0.162 | 0.189 | Hemostatic | 0.189 0.037 CID_2201 | CID_2201 | |
| 0.046 | 0.106 | 0.064 | Interferon inducer | 0.064 0.044 CID_2201 | CID_2201 | |
| 0.019 | 0.081 | 0.041 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.041 0.015 CID_2201 | CID_2201 | |
| 0.037 | 0.099 | 0.097 | Carbonic anhydrase V inhibitor | 0.097 0.028 CID_2201 | CID_2201 | |
| 0.005 | 0.067 | 0.025 | Egl nine homolog 1 inhibitor | 0.025 0.005 CID_2201 | CID_2201 | |
| 0.014 | 0.076 | 0.04 | Peroxisome proliferator-activated receptor delta agonist | 0.04 0.017 CID_2201 | CID_2201 | |
| 0.02 | 0.083 | 0.042 | Carbonic anhydrase VII inhibitor | 0.042 0.038 CID_2201 | CID_2201 | |
| 0.092 | 0.157 | 0.143 | Acetylcholine M1 receptor antagonist | 0.143 0.081 CID_2201 | CID_2201 | |
| 0.016 | 0.082 | 0.073 | Farnesoid X receptor agonist | 0.073 0.006 CID_2201 | CID_2201 | |
| 0.024 | 0.089 | 0.108 | NMDA receptor subunit 3B antagonist | 0.108 0.01 CID_2201 | CID_2201 | |
| 0.046 | 0.114 | 0.066 | Phosphodiesterase 1C inhibitor | 0.066 0.035 CID_2201 | CID_2201 | |
| 0.036 | 0.104 | 0.071 | Thromboxane synthase inhibitor | 0.071 0.017 CID_2201 | CID_2201 | |
| 0.051 | 0.121 | 0.089 | Myeloperoxidase inhibitor | 0.089 0.051 CID_2201 | CID_2201 | |
| 0.025 | 0.098 | 0.061 | Glutamate (mGluR group III) agonist | 0.061 0.018 CID_2201 | CID_2201 | |
| 0.029 | 0.104 | 0.085 | NMDA 2C receptor antagonist | 0.085 0.022 CID_2201 | CID_2201 | |
| 0.016 | 0.093 | 0.09 | NMDA receptor subunit 3A antagonist | 0.09 0.009 CID_2201 | CID_2201 | |
| 0.023 | 0.102 | 0.071 | Carbonic anhydrase XIV inhibitor | 0.071 0.02 CID_2201 | CID_2201 | |
| 0.076 | 0.155 | 0.111 | Cytokine production inhibitor | 0.111 0.098 CID_2201 | CID_2201 | |
| 0.103 | 0.183 | 0.184 | MAP kinase kinase 2 inhibitor | 0.184 0.093 CID_2201 | CID_2201 | |
| 0.088 | 0.168 | 0.237 | Cell wall synthesis inhibitor | 0.237 0.019 CID_2201 | CID_2201 | |
| 0.044 | 0.125 | 0.062 | Beta 3 adrenoreceptor antagonist | 0.062 0.05 CID_2201 | CID_2201 | |
| 0.01 | 0.092 | 0.024 | Beta 1 adrenoreceptor agonist | 0.024 0.014 CID_2201 | CID_2201 | |
| 0.153 | 0.237 | 0.367 | Vasodilator, peripheral | 0.367 0.067 CID_2201 | CID_2201 | |
| 0.017 | 0.102 | 0.068 | Peroxisome proliferator-activated receptor alpha agonist | 0.068 0.023 CID_2201 | CID_2201 | |
| 0.059 | 0.147 | 0.248 | DNA intercalator | 0.248 0.016 CID_2201 | CID_2201 | |
| 0.057 | 0.145 | 0.214 | Protein kinase (CK2) alpha inhibitor | 0.214 0.022 CID_2201 | CID_2201 | |
| 0.014 | 0.103 | 0.152 | Nicotinic acid receptor 2 agonist | 0.152 0.004 CID_2201 | CID_2201 | |
| 0.107 | 0.196 | 0.234 | Non-steroidal antiinflammatory agent | 0.234 0.05 CID_2201 | CID_2201 | |
| 0.017 | 0.107 | 0.083 | NMDA 2A receptor antagonist | 0.083 0.019 CID_2201 | CID_2201 | |
| 0.008 | 0.098 | 0.118 | Retinoid X beta receptor agonist | 0.118 0.003 CID_2201 | CID_2201 | |
| 0.165 | 0.258 | 0.232 | DNA directed DNA polymerase inhibitor | 0.232 0.203 CID_2201 | CID_2201 | |
| 0.014 | 0.108 | 0.043 | Retinoid X gamma receptor antagonist | 0.043 0.004 CID_2201 | CID_2201 | |
| 0.075 | 0.169 | 0.145 | NADPH oxidase inhibitor | 0.145 0.058 CID_2201 | CID_2201 | |
| 0.021 | 0.116 | 0.043 | Acid-sensing ion channel blocker | 0.043 0.024 CID_2201 | CID_2201 | |
| 0.012 | 0.108 | 0.054 | Retinoic acid gamma receptor agonist | 0.054 0.003 CID_2201 | CID_2201 | |
| 0.045 | 0.141 | 0.17 | NMDA receptor antagonist | 0.17 0.019 CID_2201 | CID_2201 | |
| 0.009 | 0.106 | 0.038 | AMPA 2 receptor antagonist | 0.038 0.015 CID_2201 | CID_2201 | |
| 0.065 | 0.164 | 0.116 | Cyclooxygenase 2 inhibitor | 0.116 0.085 CID_2201 | CID_2201 | |
| 0.008 | 0.108 | 0.049 | Leukotriene B4 receptor 1 antagonist | 0.049 0.008 CID_2201 | CID_2201 | |
| 0.043 | 0.143 | 0.199 | Potassium channel (Ca-activated) activator | 0.199 0.015 CID_2201 | CID_2201 | |
| 0.013 | 0.114 | 0.172 | Purinergic P2Y14 antagonist | 0.172 0.004 CID_2201 | CID_2201 | |
| 0.076 | 0.177 | 0.144 | Cytidine deaminase inhibitor | 0.144 0.08 CID_2201 | CID_2201 | |
| 0.001 | 0.102 | 0.007 | Insulin like growth factor 3 antagonist | 0.007 0.004 CID_2201 | CID_2201 | |
| 0.01 | 0.113 | 0.131 | Retinoic acid receptor agonist | 0.131 0.003 CID_2201 | CID_2201 | |
| 0.104 | 0.21 | 0.168 | Antiamyloidogenic | 0.168 0.125 CID_2201 | CID_2201 | |
| 0.088 | 0.202 | 0.144 | Sphingosine 1-phosphate receptor 2 antagonist | 0.144 0.049 CID_2201 | CID_2201 | |
| 0.061 | 0.175 | 0.099 | MAP kinase kinase inhibitor | 0.099 0.097 CID_2201 | CID_2201 | |
| 0.007 | 0.124 | 0.109 | Retinoid X gamma receptor agonist | 0.109 0.003 CID_2201 | CID_2201 | |
| 0.097 | 0.215 | 0.202 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.202 0.099 CID_2201 | CID_2201 | |
| 0.012 | 0.138 | 0.04 | DNA gyrase subunit B inhibitor | 0.04 0.023 CID_2201 | CID_2201 | |
| 0.01 | 0.139 | 0.042 | Carnitine palmitoyltransferase inhibitor | 0.042 0.014 CID_2201 | CID_2201 | |
| 0.011 | 0.142 | 0.04 | Carnitine palmitoyltransferase 1 inhibitor | 0.04 0.015 CID_2201 | CID_2201 | |
| 0.028 | 0.161 | 0.044 | Beta adrenoreceptor agonist | 0.044 0.037 CID_2201 | CID_2201 | |
| 0.011 | 0.149 | 0.122 | NMDA 2D receptor antagonist | 0.122 0.004 CID_2201 | CID_2201 | |
| 0.095 | 0.238 | 0.166 | Free radical scavenger | 0.166 0.127 CID_2201 | CID_2201 | |
| 0.133 | 0.279 | 0.312 | Antithrombotic | 0.312 0.08 CID_2201 | CID_2201 | |
| 0.061 | 0.208 | 0.132 | Cyclooxygenase inhibitor | 0.132 0.086 CID_2201 | CID_2201 | |
| 0.102 | 0.257 | 0.155 | CC chemokine 6 receptor antagonist | 0.155 0.016 CID_2201 | CID_2201 | |
| 0.008 | 0.169 | 0.064 | Glutamate (mGluR2) agonist | 0.064 0.01 CID_2201 | CID_2201 | |
| 0.029 | 0.19 | 0.062 | Sirtuin 1 inhibitor | 0.062 0.055 CID_2201 | CID_2201 | |
| 0.011 | 0.176 | 0.073 | Glutamate (mGluR group II) agonist | 0.073 0.01 CID_2201 | CID_2201 | |
| 0.035 | 0.201 | 0.074 | Adrenaline agonist | 0.074 0.067 CID_2201 | CID_2201 | |
| 0.026 | 0.198 | 0.091 | Sphingosine 1-phosphate receptor 5 agonist | 0.091 0.01 CID_2201 | CID_2201 | |
| 0.115 | 0.288 | 0.242 | Transcription factor STAT3 inhibitor | 0.242 0.09 CID_2201 | CID_2201 | |
| 0.077 | 0.252 | 0.195 | Polo-like kinase-3 inhibitor | 0.195 0.048 CID_2201 | CID_2201 | |
| 0.05 | 0.229 | 0.181 | ABCA1 expression enhancer | 0.181 0.012 CID_2201 | CID_2201 | |
| 0.038 | 0.22 | 0.131 | Mediator release inhibitor | 0.131 0.038 CID_2201 | CID_2201 | |
| 0.013 | 0.2 | 0.089 | NMDA 2 receptor antagonist | 0.089 0.038 CID_2201 | CID_2201 | |
| 0.064 | 0.256 | 0.212 | Diuretic | 0.212 0.04 CID_2201 | CID_2201 | |
| 0.031 | 0.226 | 0.066 | Calcium channel L-type blocker | 0.066 0.058 CID_2201 | CID_2201 | |
| 0.001 | 0.201 | 0.014 | Mannitol 2-dehydrogenase inhibitor | 0.014 0.003 CID_2201 | CID_2201 | |
| 0.018 | 0.23 | 0.065 | Glutamate (mGluR8) antagonist | 0.065 0.005 CID_2201 | CID_2201 | |
| 0.03 | 0.242 | 0.096 | 5-Lipoxygenase inhibitor | 0.096 0.067 CID_2201 | CID_2201 | |
| 0.008 | 0.239 | 0.017 | Tryptophan hydroxylase 1 inhibitor | 0.017 0.013 CID_2201 | CID_2201 | |
| 0.005 | 0.239 | 0.024 | Bombesin 3 receptor agonist | 0.024 0.009 CID_2201 | CID_2201 | |
| 0.067 | 0.301 | 0.197 | NOS3 expression enhancer | 0.197 0.042 CID_2201 | CID_2201 | |
| 0.004 | 0.243 | 0.031 | Prostaglandin EP3 antagonist | 0.031 0.02 CID_2201 | CID_2201 | |
| 0.15 | 0.392 | 0.487 | Calcium channel L-type activator | 0.487 0.033 CID_2201 | CID_2201 | |
| 0.035 | 0.279 | 0.065 | Heme oxygenase stimulant | 0.065 0.035 CID_2201 | CID_2201 | |
| 0.009 | 0.256 | 0.178 | Prostaglandin EP2 antagonist | 0.178 0.008 CID_2201 | CID_2201 | |
| 0.014 | 0.262 | 0.068 | Neuraminidase (Influenza A) inhibitor | 0.068 0.008 CID_2201 | CID_2201 | |
| 0.013 | 0.262 | 0.107 | Peroxisome proliferator-activated receptor gamma agonist | 0.107 0.024 CID_2201 | CID_2201 | |
| 0.069 | 0.321 | 0.462 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.462 0.009 CID_2201 | CID_2201 | |
| 0.028 | 0.284 | 0.087 | Somatostatin 1 agonist | 0.087 0.044 CID_2201 | CID_2201 | |
| 0.005 | 0.267 | 0.027 | Bombesin agonist | 0.027 0.01 CID_2201 | CID_2201 | |
| 0.005 | 0.283 | 0.03 | Diacylglycerol O-acyltransferase 1 inhibitor | 0.03 0.019 CID_2201 | CID_2201 | |
| 0.027 | 0.307 | 0.189 | Glutamate receptor antagonist | 0.189 0.029 CID_2201 | CID_2201 | |
| 0.033 | 0.317 | 0.116 | Cyclooxygenase 1 inhibitor | 0.116 0.084 CID_2201 | CID_2201 | |
| 0.008 | 0.296 | 0.029 | Liver X receptor alpha antagonist | 0.029 0.021 CID_2201 | CID_2201 | |
| 0.02 | 0.313 | 0.113 | Prostaglandin F2 alpha antagonist | 0.113 0.008 CID_2201 | CID_2201 | |
| 0.012 | 0.313 | 0.038 | Purinergic P2Y2 antagonist | 0.038 0.018 CID_2201 | CID_2201 | |
| 0.042 | 0.361 | 0.337 | Protein kinase (CK1) gamma 3 inhibitor | 0.337 0.011 CID_2201 | CID_2201 | |
| 0.005 | 0.331 | 0.036 | Prostacyclin antagonist | 0.036 0.02 CID_2201 | CID_2201 | |
| 0.034 | 0.363 | 0.307 | Protein kinase (CK1) gamma 1 inhibitor | 0.307 0.019 CID_2201 | CID_2201 | |
| 0.046 | 0.381 | 0.109 | Histone deacetylase SIRT1 inhibitor | 0.109 0.106 CID_2201 | CID_2201 | |
| 0.029 | 0.364 | 0.217 | Protein kinase (CK1) gamma 2 inhibitor | 0.217 0.027 CID_2201 | CID_2201 | |
| 0.043 | 0.385 | 0.221 | Hypolipemic | 0.221 0.082 CID_2201 | CID_2201 | |
| 0.007 | 0.361 | 0.027 | Liver X receptor antagonist | 0.027 0.026 CID_2201 | CID_2201 | |
| 0.006 | 0.364 | 0.188 | Prostaglandin E2 antagonist | 0.188 0.006 CID_2201 | CID_2201 | |
| 0.013 | 0.374 | 0.113 | Neuraminidase (influenza) inhibitor | 0.113 0.013 CID_2201 | CID_2201 | |
| 0.073 | 0.444 | 0.337 | MAP-kinase-activated kinase 5 inhibitor | 0.337 0.014 CID_2201 | CID_2201 | |
| 0.008 | 0.404 | 0.115 | Neuraminidase inhibitor | 0.115 0.011 CID_2201 | CID_2201 | |
| 0.024 | 0.425 | 0.415 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.415 0.015 CID_2201 | CID_2201 | |
| 0.006 | 0.408 | 0.132 | Prostaglandin antagonist | 0.132 0.012 CID_2201 | CID_2201 | |
| 0.017 | 0.435 | 0.102 | M18 aspartyl aminopeptidase inhibitor | 0.102 0.089 CID_2201 | CID_2201 | |
| 0.015 | 0.435 | 0.232 | Protein kinase (CK1) gamma inhibitor | 0.232 0.035 CID_2201 | CID_2201 | |
| 0.024 | 0.449 | 0.147 | Breast cancer-resistant protein inhibitor | 0.147 0.025 CID_2201 | CID_2201 | |
| 0.015 | 0.47 | 0.061 | Autotaxin inhibitor | 0.061 0.027 CID_2201 | CID_2201 | |
| 0.066 | 0.538 | 0.226 | Catenin beta inhibitor | 0.226 0.018 CID_2201 | CID_2201 | |
| 0.004 | 0.484 | 0.042 | Factor XI inhibitor | 0.042 0.014 CID_2201 | CID_2201 | |
| 0.005 | 0.498 | 0.063 | Factor XIa inhibitor | 0.063 0.011 CID_2201 | CID_2201 | |
| 0.042 | 0.562 | 0.128 | Sigma receptor agonist | 0.128 0.104 CID_2201 | CID_2201 | |
| 0.013 | 0.534 | 0.241 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.241 0.034 CID_2201 | CID_2201 | |
| 0.005 | 0.527 | 0.036 | Peroxisome proliferator-activated receptor delta antagonist | 0.036 0.019 CID_2201 | CID_2201 | |
| 0.004 | 0.532 | 0.032 | Prostaglandin D2 agonist | 0.032 0.02 CID_2201 | CID_2201 | |
| 0.003 | 0.535 | 0.056 | Prostaglandin EP1 antagonist | 0.056 0.006 CID_2201 | CID_2201 | |
| 0.026 | 0.562 | 0.207 | Streptokinase A inhibitor | 0.207 0.129 CID_2201 | CID_2201 | |
| 0.014 | 0.554 | 0.203 | Protein kinase C nu inhibitor | 0.203 0.046 CID_2201 | CID_2201 | |
| 0.035 | 0.606 | 0.531 | Immunosuppressant | 0.531 0.025 CID_2201 | CID_2201 | |
| 0.015 | 0.593 | 0.074 | Factor IXa inhibitor | 0.074 0.019 CID_2201 | CID_2201 | |
| 0.019 | 0.621 | 0.11 | Adenine nucleotide translocase inhibitor | 0.11 0.004 CID_2201 | CID_2201 | |
| 0.047 | 0.662 | 0.248 | Lipocortins synthesis antagonist | 0.248 0.034 CID_2201 | CID_2201 | |
| 0.013 | 0.657 | 0.168 | Thrombolytic | 0.168 0.069 CID_2201 | CID_2201 | |
| 0.008 | 0.655 | 0.028 | DNA topoisomerase IV inhibitor | 0.028 0.027 CID_2201 | CID_2201 | |
| 0.022 | 0.671 | 0.298 | Cardiotonic | 0.298 0.057 CID_2201 | CID_2201 | |
| 0.007 | 0.664 | 0.071 | Leukotriene synthesis inhibitor | 0.071 0.043 CID_2201 | CID_2201 | |
| 0.015 | 0.674 | 0.112 | Potassium channel large-conductance Ca-activated activator | 0.112 0.019 CID_2201 | CID_2201 | |
| 0.003 | 0.664 | 0.042 | Somatostatin 5 antagonist | 0.042 0.017 CID_2201 | CID_2201 | |
| 0.013 | 0.711 | 0.404 | Amyloid beta precursor protein antagonist | 0.404 0.006 CID_2201 | CID_2201 | |
| 0.015 | 0.714 | 0.154 | Farnesoid X receptor antagonist | 0.154 0.048 CID_2201 | CID_2201 | |
| 0.008 | 0.718 | 0.066 | Nicotinic acid receptor 1 agonist | 0.066 0.014 CID_2201 | CID_2201 | |
| 0.019 | 0.734 | 0.122 | MAP3K9 inhibitor | 0.122 0.11 CID_2201 | CID_2201 | |
| 0.005 | 0.739 | 0.032 | Protein kinase C beta I inhibitor | 0.032 0.026 CID_2201 | CID_2201 | |
| 0.007 | 0.75 | 0.054 | Myc inhibitor | 0.054 0.039 CID_2201 | CID_2201 | |
| 0.029 | 0.774 | 0.102 | Folate antagonist | 0.102 0.061 CID_2201 | CID_2201 | |
| 0.008 | 0.768 | 0.052 | DNA gyrase subunit A inhibitor | 0.052 0.015 CID_2201 | CID_2201 | |
| 0.003 | 0.764 | 0.032 | Protocollagen prolyl hydroxylase inhibitor | 0.032 0.013 CID_2201 | CID_2201 | |
| 0.012 | 0.79 | 0.24 | P-glycoprotein inhibitor | 0.24 0.045 CID_2201 | CID_2201 | |
| 0.031 | 0.83 | 0.338 | Sodium/bile acid cotransporter inhibitor | 0.338 0.048 CID_2201 | CID_2201 | |
| 0.017 | 0.819 | 0.227 | Hypoglycemic | 0.227 0.091 CID_2201 | CID_2201 | |
| 0.005 | 0.81 | 0.047 | Maillard reaction inhibitor | 0.047 0.046 CID_2201 | CID_2201 | |
| 0.019 | 0.837 | 0.079 | Hematopoietic | 0.079 0.075 CID_2201 | CID_2201 | |
| 0.01 | 0.828 | 0.218 | Insulin secretagoues | 0.218 0.028 CID_2201 | CID_2201 | |
| 0.005 | 0.831 | 0.175 | M17 leucyl aminopeptidase inhibitor | 0.175 0.042 CID_2201 | CID_2201 | |
| 0.017 | 0.853 | 0.135 | Interleukin 4 antagonist | 0.135 0.065 CID_2201 | CID_2201 | |
| 0.004 | 0.85 | 0.086 | DNA gyrase inhibitor | 0.086 0.023 CID_2201 | CID_2201 | |
| 0.014 | 0.867 | 0.116 | DNA polymerase I inhibitor | 0.116 0.072 CID_2201 | CID_2201 | |
| 0.013 | 0.876 | 0.408 | Antiinflammatory | 0.408 0.134 CID_2201 | CID_2201 | |
| 0.036 | 0.929 | 0.238 | Interleukin 2 agonist | 0.238 0.133 CID_2201 | CID_2201 | |
| 0.005 | 0.928 | 0.294 | Cyclophilin D inhibitor | 0.294 0.168 CID_2201 | CID_2201 | |
| 0.007 | 0.93 | 0.055 | Carnitine palmitoyltransferase 1B inhibitor | 0.055 0.022 CID_2201 | CID_2201 | |
| 0.005 | 0.93 | 0.092 | Chelator | 0.092 0.089 CID_2201 | CID_2201 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |